Avadel Pharmaceuticals (AVDL)
NASDAQ: AVDL
· Real-Time Price · USD
8.63
-0.26 (-2.92%)
At close: May 01, 2025, 3:59 PM
9.00
4.34%
After-hours: May 01, 2025, 06:54 PM EDT
Avadel Pharmaceuticals Revenue
Avadel Pharmaceuticals reported an annual revenue of $169.12M, reflecting a 504.79% growth. For the quarter ending December 31, 2024, Avadel Pharmaceuticals generated $50.41M in revenue.
Revenue (ttm)
$169.12M
Revenue Growth
504.79%
Price / Sales Ratio
5.91
Revenue / Employee
$899.56K
Employees
188
Market Cap
833.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 169.12M | +504.79% |
| Dec 31, 2023 | 27.96M | +Infinity% |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | -100.00% |
| Dec 31, 2020 | 22.33M | n/a |